Rheumatoid Arthritis (RA) Clinical Trials

Find Rheumatoid Arthritis (RA) Clinical Trials Near You

Prognostic Factors and Predictors of Disease Flare in Patients With Rheumatoid Arthritis

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The goal of this observational study is to help find better ways to predict when a flare of your disease (rheumatoid arthritis) might happen. By looking at your registered data, symptoms, disease characteristics, and specific markers in your blood, the investigators hope to help doctors make better decisions about your treatment in the future. The main question it aims to answer is: Can specific patient data, disease characteristics, drug history, or markers in a patient's blood be used to predict when a rheumatoid arthritis flare is about to happen? Participants already diagnosed with rheumatoid arthritis and who have their disease controlled will be followed up every 3 months for any signs or symptoms of a flare.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Age: patients \>18 years old.

• Patients with rheumatoid arthritis diagnosed according to the 2010 American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology Classification Criteria for RA.

• Clinical remission or low disease activity according to the disease activity score in 28 joints (DAS28).

Locations
Other Locations
Egypt
Rheumatology and Rehabilitation Department, Faculty of Medicine, Sohag University
RECRUITING
Sohag
Contact Information
Primary
Esraa Mohamed Mahmoud Sayed
esraamahmoud@med.sohag.edu.eg
+2 01016090864
Time Frame
Start Date: 2026-02-01
Estimated Completion Date: 2027-08
Participants
Target number of participants: 200
Treatments
Flare group
patients who will have at least one flare of rheumatoid arthritis during the study period
Non-flare group
Patients who will have no flares of rheumatoid arthritis disease during the study period
Related Therapeutic Areas
Sponsors
Leads: Sohag University

This content was sourced from clinicaltrials.gov